<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1538973079464292&amp;ev=PageView&amp;noscript=1">
News
University of Kentucky Spotlights GLA Grantee
March 31, 2026

Pictured: Brian Stevenson, Ph.D., displays a preserved tick specimen in his laboratory. Photo by Jeremy Blackburn, UK Research Communications.

Learn More

Dr. Stevenson Kentucky researcher holding specimen
News
Global Lyme Alliance Attends HHS National Roundtable on Lyme Disease
December 16, 2025

Global Lyme Alliance attends HHS roundtable on Lyme disease, discussing patient care, diagnostics, and research advancements with key stakeholders. On December 15, the U.S. Department of Health and Hu...

Learn More

News
Global Lyme Alliance to Participate in HHS National Lyme Disease Roundtable on “Invisible Illness”
December 12, 2025

On December 15th, GLA will participate in the HHS National Lyme Disease Roundtable to discuss advancing care and policy for Lyme disease and related chronic conditions. The U.S. Department of Health a...

Learn More

News
A Tribute to Dr. Amiram Katz: A Healer, Innovator & Advocate to the Lyme Community
December 10, 2025

We are heartbroken by the sudden passing of Dr. Amiram Katz, MD, DABPN— a brilliant neurologist, innovator, and deeply compassionate physician.

Learn More

News
Tonix Pharmaceuticals is Developing an Antibody for Lyme Disease Prevention
October 23, 2025

Based on research conducted at UMass Medical School, TNX-4800 is a long-acting monoclonal antibody now being licensed to Tonix Pharmaceuticals for further development as single-dose, seasonal protecti...

Learn More

blacklegged tick on leaf
University of Kentucky Spotlights GLA Grantee
Global Lyme Alliance Attends HHS National Roundtable on Lyme Disease
Global Lyme Alliance to Participate in HHS National Lyme Disease Roundtable on “Invisible Illness”
A Tribute to Dr. Amiram Katz: A Healer, Innovator & Advocate to the Lyme Community
Tonix Pharmaceuticals is Developing an Antibody for Lyme Disease Prevention

Posts by Tag

See all

All News

Global Lyme Alliance Attends HHS National Roundtable on Lyme Disease
December 16, 2025
Global Lyme Alliance attends HHS roundtable on Lyme disease, discussing patient care, diagnostics, and research advancements with key stakeholders. On December 15, the U.S. Department of Health and Hu...
Read More
2025 GLA Research Symposium: Advancing the Future of Lyme Disease Research
June 6, 2025
GLA's 2025 Research Symposium united top scientists to drive innovation and collaboration in Lyme disease research, showcasing groundbreaking advancements and fostering new partnerships. Each year, Gl...
Read More
Global Lyme Alliance Opens 2025 Funding Cycle for Lyme and Tick-Borne Disease Research
May 29, 2025
May 28, 2025 -- Global Lyme Alliance (GLA), the leading nonprofit dedicated to combatting Lyme disease through research, awareness, and patient support, is pleased to announce the opening of its 2025 ...
Read More
Could Lactate Dehydrogenase Be Lyme Disease’s "Achilles Heel"?
April 17, 2025
Could lactate dehydrogenase be the key to treating Lyme disease? Learn how targeting this enzyme could inform future treatment strategies. A recent study identified an enzyme in Borrelia burgdorferi, ...
Read More
Lyme Disease Crisis Addressed During HHS Hearing
March 17, 2025
Robert F. Kennedy Jr. & Senator Collins discuss the Lyme disease crisis during HHS confirmation hearing
Read More
Dr. Jutras’ Lab Wins Phase 3 of LymeX Diagnostics Prize
January 21, 2025
Dr. Jutras' lab wins Phase 3 of LymeX Diagnostics Prize for the innovative Lyme disease test using monoclonal antibodies and immuno-PCR. The LymeX Diagnostics Prize, a competition to accelerate the de...
Read More
GLA Funded Researcher Dr. Brandon Jutras and Lab Advance to Phase 3 of Lyme X Diagnostic Prize
April 11, 2024
After having been selected for phase 2 in February, GLA- funded investigator Dr. Brandon Jutras and his lab are one of the six talented groups advancing to Phase 3 of the LymeX Diagnostics Prize. Dr. ...
Read More
Chronic and Persistent Lyme Symptoms: CDC Update Underscores Progress
October 30, 2023
The CDC's update on Lyme infections is a shift in tone on the long-lasting symptoms and challenges faced by individuals. As acceptance of 'long COVID' and the concept of persistent illnesses grows in ...
Read More
Center for Lyme Action Publishes "The State of Lyme Disease Research"
July 31, 2023
Research paper recommends critical federal appropriations for Lyme and tick-borne disease Center for Lyme Action, the leading nonprofit dedicated to growing federal funding for Lyme and tick-borne dis...
Read More
Emerging Tick Bite-Associated Meat Allergy Potentially Affects Thousands
July 31, 2023
The US Centers for Disease Control (CDC) and Prevention issued two reports about alpha-gal syndrome, which can result in a severe allergy to red meat and related products. "it is estimated that as man...
Read More
VIEW MORE
GLA
Global Lyme Alliance
PO Box 25495
New York, NY 10087-5495

2023 © Copyright Global Lyme Alliance. All rights reserved.

Disclaimer: The above material is provided for information purposes only. The material (a) is not nor should be considered, or used as a substitute for, medical advice, diagnosis, or treatment, nor (b) does it necessarily represent endorsement by or an official position of Global Lyme Alliance, Inc. or any of its directors, officers, advisors or volunteers. Advice on the testing, treatment or care of an individual patient should be obtained through consultation with a physician who has examined that patient or is familiar with that patient’s medical history. Global Lyme Alliance, Inc. makes no warranties of any kind regarding this Website, including as to the accuracy, completeness, currency or reliability of any information contained herein, and all such warranties are expressly disclaimed.